ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TECX vs ZURA // FORWARD P/E MULTIPLE

Tectonic Therapeutic Inc. (NASDAQ) VS. Zura Bio Limited (Class A) (NASDAQ) • 15-METRIC TALLY: TECX 1 — ZURA 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECX VS. ZURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TECX ZURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -15.04% -17.51% +2.47 TECX /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.9 48.5 -14.60 ZURA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $386.7M $389.2M -$2.5M ZURA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TECX REV ZURA REV TECX GROSS % ZURA GROSS % TECX FCF ZURA FCF
FY 2025 $235.3M $210.7M — — -$60.3M -$64.9M
FY 2024 $162.4M $154.5M — — -$59.2M -$28.2M
FY 2023 $125.0M $175.4M — — -$40.7M -$15.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECX // BETA —
ZURA // BETA —